Helicobacter pylori and the null genotype of glutathione-S-transferase- μ in patients with gastric adenocarcinoma

Cancer

Volumn 82, Issue 2, 1998, Pages 268-273

  Ng, Enders K W ^a   Sung, Joseph J Y ^a   Ling, Thomas K W ^a   Ip, S M ^a   Lau, James Y W ^a   Chan, Angus C W ^a   Liew, C T ^a   Chung, S C Sydney ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenocarcinoma; Carcinogenesis; Glutathione S transferase; Helicobacter pylori; Host factor; Stomach

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GENE DELETION; GENOTYPE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; AGED; CARCINOGENS; CARCINOMA; CASE-CONTROL STUDIES; DYSPEPSIA; EXONS; FEMALE; GASTRECTOMY; GENE DELETION; GENOTYPE; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0031985029     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980115)82:2<268::AID-CNCR4>3.0.CO;2-N     Document Type: Article

References (35)

1. World Health Organization. The evaluation of carcinogenic risks to humans, Monograph No. 61. Lyon, France: International Agency for Research on Cancer, 1994.
2. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
5. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994;343:234-4.
6. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylon infections. Epidemiol Rev 1991;13:42-59.
7. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
8. Crabtree JE, Figura JD, Taylor JI, Bugnoli M, Armellini D, Tompkins DS. Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol 1992;45:733-4.
9. Peek RM Jr., Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;73:760-70.
10. Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
11. Crabtree JE, Wyatt JI, Sobalo GM, Miller G, Tompkins DS, Primrose JN, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
12. Wolf CR, Smith CAD, Forman D. Metabolic polymorphisms in carcinogen metabolizing enzymes and cancer susceptibility. Br Med Bull 1994;50:718-31.
13. Board PG, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990;48:357-69.
14. Seidegard J, Pero RW, Markowitz M, Roush G, Miller WR, Beattie EJ. Isoenzymes of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990;11:33-6.
15. Hegerty AHM, Fitzgerald D, Smith A, et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 1994;343:266-7.
16. Sambrook J, Fritsch EF, Manniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Ho SA, Hoyle JA, Lewis FA, Secker AD, Cross D, Mapstone NP. Direct polymerase chain reaction for detection of Helicobacter pylori in humans and animals. J Clin Microbiol 1991;29:2543-9.
18. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
19. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
20. Craanen ME, Blok P, Dekker W, Tytgat GNT. Helicobacter pylori and gastric cancer. Gut 1994;35:1372-4.
21. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
22. Menegatti M, Vaira D, Miglioli M, Holton J, Vergur M, Biasco G, et al. Helicobacter pylori in patients with gastric and nongastric cancer. Am J Gastroenterol 1995;90:1278-81.
23. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
24. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(Suppl 1):S37-S43.
25. Xiang Z, Centsini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
26. Cover TL, Glupczynski Y, Lage AP, Tummuru MK, Perez-Perez GI, Blaser MJ. Serologic detection of infection with CagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
27. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33:1203-5
28. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.
29. Kuipers EJ, Hyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppression therapy-implications for long term safety. Am J Gastroenterol 1995;90:1401-6.
30. Keefer LK, Roller PP. N-nitrosation by nitrite ion in a neutral and basal medium. Science 1973;181:1245-7
31. Dix TA, Marnett LJ. Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation. Science 1983;221:77-9.
32. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992;27:337-84.
33. Zheng GQ, Kenney PM, Zhang J, Lam LK. Chemoprevention of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil. Nutr Cancer 1993;19:77-86.
34. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996;17:881-4.
35. Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K, et al. Genetic polymorphisms of cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer 1996;77:1654-61.